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Introduction. Psoriatic arthritis (APs) is a chronic seronegative inflammatory arthropathy, 
associated with skin psoriasis. Sometimes it can precede the skin psoriatic lesions. Etiology and 
pathogenesis remain unknown, but the genetic predisposition, the influence of the immune 
system and the environment are important in the development of the disease. APs is an 
invalidating disease with a different presentation in time, at one time it predominates as skin 
disease, and another time as articular disease, with erosive and destructive joint changes, which 
is found in about 40-60% of patients. Thus, a complex approach of the clinical features of the 
disease is needed, in order to make a correct and timely diagnosis of the disease.  
Aim of the study. investigation of the evolution of psoriatic arthritis in patients without skin 
psoriasis  
Materials and methods. the study group contains 40 patients diagnosed with psoriatic arthritis 
established in accordance with the CASPAR (2006) diagnostic criteria, admitted to the 
rheumatology and arthrology department of IMSP SCR Timofei Mosneaga during the period 
2015-2017. In order to highlight the evolutionary particularities, the patients were grouped into 2 
groups: I group (30 patients) psoriatic arthritis with skin psoriasis, II group (10 patients) psoriatic 
arthritis without skin psoriasis. Then group I and II were separated into 5 subgroups depending 
on the clinical variant of the disease. The description of each group was made by gender, mean 
age and the average age of joint affection.  
Results. The study performed on a group of 40 patients revealed the clinical particularities of the 
evolutionary variants of psoriatic arthritis, characterized by a wide variety of manifestations of 
the articular syndrome, expressed by 5 clinical types: polyarticular (31 %), axial (25.5%), 
oligoarticular (17.4%), distal interphalangeal (14.5%) and mutilating (11.6%), as well as 
peculiarities of extraarticular disorders.  
Conclusions. Severity of joint damage was assessed in relation to the presence or absence of 
skin manifestations of psoriazis. It has been established that the association of cutaneous 
psoriasis aggravates the clinical evolution of vertebral column lesions, especially in the 
polyarticular variant and less in the axial and mutilating variant.  
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Introduction. Combined therapy, clopidogrel plus aspirin, prevents secondary thrombotic in 
acute coronary syndromes (ACS), after percutaneous coronary interventions (PCI) with 
placement of a coronary artery stent. Clopidogrel is activated in the liver by cytochrome P450 
enzymes. CYP2C19 is the principal enzyme. The most common loss-of-function variant is 
